Literature DB >> 29184688

Age and factors associated with access and time to post-operative adjuvant chemotherapy in colon cancer: a French epidemiological study.

Jean Capsec1, Carole Lefebvre1, Fabienne Chupé1, Patrick Heitzmann1, Céline Raveneau1, Véronique Dardaine-Giraud2, Carine Sauger2, Jean-Paul Lagasse3, Kevin Kraft4, Claude Linassier1, Etienne Dorval2.   

Abstract

BACKGROUND: Studies have shown the negative prognostic impact of increased time between colectomy and postoperative adjuvant chemotherapy (AC) in colon cancer (CC). Our aim was to investigate the role of age and non-organizational factors on access and time to AC.
METHODS: All adult patients undergoing surgery for stage II or III CC in the "Région Centre-Val de Loire" in 2013, were selected. Time to AC and socio-demographic factors were collected. Logistic regression modeling was used to identify factors associated with access to AC, and a multivariate analysis performed to identify factors associated with time to AC.
RESULTS: Among 404 stage II or III patients who underwent colectomy, 182 (45%; sex ratio 1.5; mean age 67.6 years; range 32-90) received AC. AC patients were younger than those without AC (67.6 vs. 77.9 years) and the difference was even greater for stage III patients (69.0 vs. 82.4). The median time to AC was 48 days, exceeding 42 days in 60% of cases. Living alone, postoperative morbidities, and emergency colectomy were independently associated with increased time to AC. Age and other factors were not associated with delayed AC.
CONCLUSIONS: Emergency colectomy, postoperative morbidities, and living alone are associated with increased time to AC. Organizational measures to reduce the time to AC are therefore unlikely to have an impact. In contrast, age is not associated with increased time to AC, but to access to AC. Reasons for omitting AC in older patients requires further study.

Entities:  

Keywords:  Colonic neoplasms; adjuvant chemotherapy (AC); epidemiology; geriatrics

Year:  2017        PMID: 29184688      PMCID: PMC5674256          DOI: 10.21037/jgo.2017.06.13

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  24 in total

1.  Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years.

Authors:  Hanna K Sanoff; William R Carpenter; Til Stürmer; Richard M Goldberg; Christopher F Martin; Jason P Fine; Nadine Jackson McCleary; Jeffrey A Meyerhardt; Joyce Niland; Katherine L Kahn; Maria J Schymura; Deborah Schrag
Journal:  J Clin Oncol       Date:  2012-06-04       Impact factor: 44.544

2.  Adjuvant chemotherapy of stage III colon cancer.

Authors:  Al B Benson
Journal:  Semin Oncol       Date:  2005-12       Impact factor: 4.929

3.  A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients.

Authors:  D J Sargent; R M Goldberg; S D Jacobson; J S Macdonald; R Labianca; D G Haller; L E Shepherd; J F Seitz; G Francini
Journal:  N Engl J Med       Date:  2001-10-11       Impact factor: 91.245

4.  Adjuvant chemotherapy for stage III colon cancer: does timing matter?

Authors:  Piotr M Czaykowski; Sharlene Gill; Hagen F Kennecke; Vallerie L Gordon; Donna Turner
Journal:  Dis Colon Rectum       Date:  2011-09       Impact factor: 4.585

5.  Age and adjuvant chemotherapy use after surgery for stage III colon cancer.

Authors:  D Schrag; L D Cramer; P B Bach; C B Begg
Journal:  J Natl Cancer Inst       Date:  2001-06-06       Impact factor: 13.506

6.  Does delaying adjuvant chemotherapy after curative surgery for colorectal cancer impair survival? A meta-analysis.

Authors:  Gaetan Des Guetz; Patrick Nicolas; Gérard-Yves Perret; Jean-François Morere; Bernard Uzzan
Journal:  Eur J Cancer       Date:  2010-04       Impact factor: 9.162

7.  Colorectal cancer treatment in older patients.

Authors:  Hanna K Sanoff; Richard M Goldberg
Journal:  Gastrointest Cancer Res       Date:  2007-11

8.  Adjuvant Therapy for Stage II and III Colon Cancer: Consensus Report of the International Society of Gastrointestinal Oncology.

Authors:  John L Marshall; Daniel G Haller; Aimery de Gramont; Howard S Hochster; Heinz-Josef Lenz; Jaffer A Ajani; Richard M Goldberg
Journal:  Gastrointest Cancer Res       Date:  2007-07

9.  Reasons physicians do not recommend and patients refuse adjuvant chemotherapy for stage III colon cancer: a population based chart review.

Authors:  Mohamed El Shayeb; Andrew Scarfe; Yutaka Yasui; Marcy Winget
Journal:  BMC Res Notes       Date:  2012-06-07

10.  Trends in colorectal cancer mortality in Europe: retrospective analysis of the WHO mortality database.

Authors:  Driss Ait Ouakrim; Cécile Pizot; Magali Boniol; Matteo Malvezzi; Mathieu Boniol; Eva Negri; Maria Bota; Mark A Jenkins; Harry Bleiberg; Philippe Autier
Journal:  BMJ       Date:  2015-10-06
View more
  1 in total

1.  Prognosis and Adherence with the National Comprehensive Cancer Network Guidelines of Patients with Biliary Tract Cancers: an Analysis of the National Cancer Database.

Authors:  Fabio Bagante; Faiz Gani; Eliza W Beal; Katiuscha Merath; Qinyu Chen; Mary Dillhoff; Jordan Cloyd; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2018-08-15       Impact factor: 3.452

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.